These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25875479)

  • 1. Correction: Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways.
    Herrmann US; Sonati T; Falsig J; Reimann RR; Dametto P; O'Connor T
    PLoS Pathog; 2015 Apr; 11(4):e1004808. PubMed ID: 25875479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission.
    Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP
    PLoS Pathog; 2016 Aug; 12(8):e1005745. PubMed ID: 27561082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease.
    Friedman-Levi Y; Meiner Z; Canello T; Frid K; Kovacs GG; Budka H; Avrahami D; Gabizon R
    PLoS Pathog; 2017 May; 13(5):e1006294. PubMed ID: 28467504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Increased Abundance of M Cells in the Gut Epithelium Dramatically Enhances Oral Prion Disease Susceptibility.
    PLOS Pathogens Staff
    PLoS Pathog; 2017 Feb; 13(2):e1006222. PubMed ID: 28212438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Mutant prion proteins increase calcium permeability of AMPA receptors, exacerbating excitotoxicity.
    Ghirardini E; Restelli E; Morini R; Bertani I; Ortolan D; Perrucci F; Pozzi D; Matteoli M; Chiesa R
    PLoS Pathog; 2020 Dec; 16(12):e1009174. PubMed ID: 33351850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Site-specific analysis of N-glycans from different sheep prion strains.
    Nakić N; Tran TH; Novokmet M; Andreoletti O; Lauc G; Legname G
    PLoS Pathog; 2021 Apr; 17(4):e1009511. PubMed ID: 33844702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.
    Jardine JG; Sok D; Julien JP; Briney B; Sarkar A; Liang CH; Scherer EM; Henry Dunand CJ; Adachi Y; Diwanji D; Hsueh J; Jones M; Kalyuzhniy O; Kubitz M; Spencer S; Pauthner M; Saye-Francisco KL; Sesterhenn F; Wilson PC; Galloway DA; Stanfield RL; Wilson IA; Burton DR; Schief WR
    PLoS Pathog; 2016 Sep; 12(9):e1005905. PubMed ID: 27627763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies.
    Donofrio G; Heppner FL; Polymenidou M; Musahl C; Aguzzi A
    J Virol; 2005 Jul; 79(13):8330-8. PubMed ID: 15956578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and neurotoxic signaling by the prion protein.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Top Curr Chem; 2011; 305():101-19. PubMed ID: 21598098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-based immunotherapeutic attempts in experimental animal models of prion diseases.
    Sakaguchi S; Ishibashi D; Matsuda H
    Expert Opin Ther Pat; 2009 Jul; 19(7):907-17. PubMed ID: 19514955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Wolbachia Blocks Viral Genome Replication Early in Infection without a Transcriptional Response by the Endosymbiont or Host Small RNA Pathways.
    PLOS Pathogens Staff
    PLoS Pathog; 2016 May; 12(5):e1005639. PubMed ID: 27159401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: 24 Hours in the Life of HIV-1 in a T Cell Line.
    Mohammadi P; Desfarges S; Bartha I; Joos B; Zangger N; Muñoz M; Günthard HF; Beerenwinkel N; Telenti A; Ciuffi A
    PLoS Pathog; 2015 Jun; 11(6):e1005006. PubMed ID: 26076473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.
    Lin JD; Feng N; Sen A; Balan M; Tseng HC; McElrath C; Smirnov SV; Peng J; Yasukawa LL; Durbin RK; Durbin JE; Greenberg HB; Kotenko SV
    PLoS Pathog; 2016 Jun; 12(6):e1005726. PubMed ID: 27304875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
    Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
    J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Bacterial immune evasion through manipulation of host inhibitory immune signaling.
    PLOS Pathogens Staff
    PLoS Pathog; 2015 Apr; 11(4):e1004813. PubMed ID: 25853824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: BILBO1 is a scaffold protein of the flagellar pocket collar in the pathogen Trypanosoma brucei.
    Florimond C; Sahin A; Vidilaseris K; Dong G; Landrein N; Dacheux D; Albisetti A; Byard EH; Bonhivers M; Robinson DR
    PLoS Pathog; 2015 Apr; 11(4):e1004844. PubMed ID: 25874582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases.
    Kovacs GG; Voigtländer T; Hainfellner JA; Budka H
    Acta Neuropathol; 2002 Sep; 104(3):320-6. PubMed ID: 12172919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein.
    Hanoux V; Wijkhuisen A; Alexandrenne C; Créminon C; Boquet D; Couraud JY
    Mol Immunol; 2009 Mar; 46(6):1076-83. PubMed ID: 19012967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation.
    PLOS Pathogens Staff
    PLoS Pathog; 2015 Apr; 11(4):e1004797. PubMed ID: 25875364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
    White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
    Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.